[1]
CHADEVE, A. 2020. A REVIEW ON PHARMACOLOGY AND THERAPEUTIC EFFECTS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian Journal of Pharmaceutical and Clinical Research. 13, 5 (May 2020), 16–21. DOI:https://doi.org/10.22159/ajpcr.2020.v13i5.36838.